Rosetta AI automatic translation company Rosetta webinar “Increase the speed of market introduction and strengthen competitive advantage -Correlation between drug development aiming for globalization and machine translation-” Held on December 13 (T

Rosetta
Rosetta AI automatic translation webinar “Increase the speed of market introduction and strengthen competitive advantage -Correlation between drug development aiming for globalization and machine translation-” Held on December 13 (Tuesday)

Rosetta Co., Ltd. (Headquarters: Chiyoda-ku, Tokyo; Representative Director: Maro Watanabe), which develops and operates high-precision AI automatic translation, will hold a free webinar titled “Increase Market Speed ​​and Strengthen Competitive Advantages-Pharmaceuticals Aiming for Globalization” Correlation between development and machine translation ~” will be held on Tuesday, December 13, 2022.
[Image

https://www.rozetta.jp/webinar/?webiner=221213-14
Please register from the participation application form in the middle of the page.
*After registration is completed, we will send you an email with the participation URL.
【Overview】
Amidst the imminence of a super-aging society, pharmaceutical companies around the world are stepping up efforts to provide new value, armed with evolving science and pharmaceutical technology, in response to ever-changing social needs.
However, Japanese pharmaceutical companies currently lag behind Western pharmaceutical companies in terms of corporate scale. In order for Japanese pharmaceutical companies to make further progress, they need to make decisions based on reliable information, improve operational efficiency, and dramatically speed up overseas
collaboration. This is where our translation solutions can help. Translation work, which currently takes a huge amount of time, can bring many benefits to drug developers by in-house production. This webinar will explore solutions to enhance the competitiveness of Japanese pharmaceutical companies under the title of “Increase Market Speed ​​and Strengthen Competitive Advantage – Correlation between Drug Development Aiming for Globalization and Machine Translation”. [Recommended for people like this]
・Persons in charge who mainly belong to the development department of pharmaceutical manufacturers
・Pharmaceutical manufacturers who need data management and statistical analysis ・Persons in charge who are considering introducing a secure and efficient translation platform
・Person in charge of a BPO company that strengthens efficiency factories and cost reduction competitiveness so that it can speed up market introduction
[Date and time]
Tuesday, December 13, 2022 14:00-14:40
[Holding method]
Held on Zoom.
For those who have applied for participation, we will send you a zoom url by email the day before the event.
【Entry fee】
free
【please note】
・Even if there are multiple participants, please apply for
participation one by one.
・Participation by other companies in the same industry or individuals may be refused.
■ About Rosetta Co., Ltd.
Rosetta develops and operates AI automatic translation under the corporate mission of “liberating our country from the spell of linguistic handicap”. Rosetta’s automatic translation has been introduced by more than 5000 companies and organizations in Japan and overseas, including pharmaceuticals, pharmaceuticals, life sciences, bio-ventures, ministries and agencies, national laboratories, universities, hospitals, chemistry, environment, energy, petroleum, food, and beverages. , agriculture, forestry and fisheries, civil engineering and construction, legal affairs, law firms, patent firms, finance, IT, communications, semiconductors, industrial machinery, electrical equipment, precision equipment, and more.
URL: https://www.rozetta.jp/
Details about this release:
https://prtimes.jp/main/html/rd/p/000000470.000006279.html


rehow

Leave a Reply

Your email address will not be published.

%d bloggers like this: